Presenter: Dr Marika Nestor, Department of Immunology, genetics and pathology, Uppsala University, Sweden Molecular radiotherapy is increasingly becoming a powerhouse in the field of cancer- and radiation therapy. By targeting a structure that is abundant on tumor cells but scarce in healthy tissues, a cancer-targeting molecule labeled with a therapeutic radionuclide can mediate the delivery […]
Call for new drug discovery projects to SciLifeLab DDD for the fall 2022 and introduction of a SciLifeLab capability for DNA encoded chemical librari
The chemical biology unit (CBCS) and the Drug discovery and development (DDD) platform at SciLifeLab have calls out for projects. CBCS is looking for projects in Chemical Biology which includes assay development for small molecule screening and profiling, as well as enabling chemistry. For more information, please visit www.cbcs.se. The DDD platform has a call […]
Program In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new pilot project proposals for drug discovery. All therapeutic modalities are of interest. Of special interest are new project ideas for new modalities including therapeutic oligonucleotides, and in collaboration with ENABLE2 https://www.ilk.uu.se/enable2/, projects for discovery of new antibiotics. Note that shorter projects for selections in phage […]
Every year, the Drug Delivery group at the Department of Pharmacy (headed by Prof. Per Artursson, Prof. Christel Bergström and Dr. Pawel Baranczewski) organizes a one-day symposium on pharmaceutical profiling. On January 19th, 2023, the 12th Uppsala University Pharmaceutical Profiling in Drug Discovery and Development Symposium will be arranged. This twelfth edition of the symposium will focus on […]
The chemical biology unit (CBCS) and the Drug discovery and development (DDD) platform at SciLifeLab have calls out for projects. CBCS is looking for projects in Chemical Biology which includes assay development for small molecule screening and profiling, as well as enabling chemistry. For more information, please visit www.cbcs.se. The DDD platform has a call looking […]
At these two seminars you will hear about the two techniques of electrosynthesis and photoredoxchemistry, used more and more today by organic chemists. We will get some background information to the techniques and examples from how it is used in Helena’s and Markus’ labs. After the seminars we hope that you better understand when the […]
A half day dedicated to kinases in drug discovery organized by SciLifeLab DDD in collaboration with AstraZeneca. Kinases continue to attract much attention in drug discovery. Since the first compounds were launched in 2001 the learning curve of how to tackle different challenges has been steep. At the symposium we hope to give a broad […]
The DDD platform at SciLifeLab supports academic drug discovery project with expertise and technical capabilities. We have, for example, platforms to develop small molecule drugs, therapeutic antibodies, oligonucleotide therapeutics, proximity-inducing agents such as bispecific antibodies and PROTACs. In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new pilot project […]
The chemical biology unit (CBCS) and the Drug discovery and development (DDD) platform at SciLifeLab have calls out for projects. CBCS is looking for projects in Chemical Biology which includes assay development for small molecule screening and profiling, as well as enabling chemistry. For more information, please visit www.cbcs.se. The DDD platform has a call looking […]
Pandemic preparedness and the generation of SARS-CoV-2 inhibitors - A new exit from SciLifeLab Drug Discovery and Development platform
Join us for an exciting webinar delving into the topic of target validation in academic drug discovery. Discover strategies for effective target validation from our experts. Register now for our joint webinar with Karolinska Institutet and SciLifeLab Drug Discovery & Development and secure your spot